Question 1

What is HCPCS code Q0237?

Accepted Answer

HCPCS code Q0237 is "Inj, tocilizumab-anoh, hospi". Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg

Question 2

What category is Q0237 in?

Accepted Answer

Q0237 belongs to HCPCS Category Q (Temporary Codes).

Question 3

When should I use HCPCS code Q0237?

Accepted Answer

Use Q0237 when billing for inj, tocilizumab-anoh, hospi. HCPCS Level II codes like this are used for items and services not covered by CPT codes, including medical supplies, equipment, drugs administered in clinical settings, and certain healthcare services.

Question 4

Is Q0237 covered by Medicare?

Accepted Answer

Coverage for Q0237 (Inj, tocilizumab-anoh, hospi) depends on medical necessity and specific Medicare guidelines. Check the applicable Local Coverage Determination (LCD) or National Coverage Determination (NCD) for detailed coverage criteria. Private insurers may have different coverage policies.

Question 5

What documentation is required for Q0237?

Accepted Answer

Documentation for Q0237 should include: the medical necessity for the item or service, supporting diagnosis codes (ICD-10), prescription or order from the treating physician, and proof that the item meets quality standards. Some items may require additional documentation like a Certificate of Medical Necessity (CMN).